L’Oréal Groupe Introduces Cell BioPrint: A Personalized Skin Analysis Device at CES 2025

IN CES 2025, L’Oréal Groupe is set to introduce L’Oréal Cell BioPrint, a new hardware device designed to provide personalized skin analysis in just five minutes. This benchtop device uses advanced proteomics—the study of how proteins in the human body influence biological processes, including skin aging—to offer insights beyond surface-level analysis.

L’Oréal Cell BioPrint aims to improve the personalization of skin care by using the science of proteomics to better understand the biology of individual skin. Proteomics, which studies how protein composition changes and affects overall health, has now been adapted to study skin intelligence. Through a collaboration with Korean startup NanoEnTek, L’Oréal has integrated laboratory technology into a credit card-sized device that can detect proprietary biomarkers in the skin. These biomarkers can reveal information about skin health over time, offering greater insight into skin health and longevity.

How L’Oréal Cell BioPrint works

The device performs a skin assessment within five minutes, analyzing various aspects of skin health, including:

• Biological age of skin: Determines the rate of skin aging at the cellular level and gives individual recommendations to help slow down this process.
• Sensitivity to ingredients: Evaluates how effectively key ingredients such as retinol can work for the user, reducing the need for trial and error.
• Proactive skin care planning: Predicts potential skin problems, such as dark spots or enlarged pores, before they become noticeable, allowing users to take preventive measures.

The process involves placing a strip of facial tape on the cheek, which is then immersed in a buffer solution. The solution is loaded into a cartridge and inserted into the BioPrint for analysis. At the same time, the Skin Connect device captures facial images and the user fills out a short questionnaire about their skin concerns.

The value of biomarker research in skin care

L’Oréal’s Advanced Research Unit has identified unique skin biomarkers that correlate with health and longevity. These biomarkers provide information that was previously only available in vitro. Using NanoEnTek microfluidic lab-on-a-chip technology, L’Oréal Cell BioPrint can analyze these markers quickly and non-invasively, offering personalized skin assessments in beauty salons.

Barbara Lavernos, Deputy CEO of Research, Innovation and Technology at L’Oréal Groupe, commented: “As the skin is our largest organ and essential for well-being, we are pleased to introduce Cell BioPrint. This technology allows people to gain a deeper understanding of their skin through biomarker analysis and proactively take charge of their skin health.”

Meeting the demand for personalized skin care

The launch of L’Oréal Cell BioPrint follows the growing trend of personalization in skin care. The global skin care market is projected to reach $125 billion by 2024, driven by consumers seeking more effective and customizable products. A recent study found that nearly 80% of skin care users rely on trial and error to find the right products, often testing multiple options before finding the right one.

By minimizing the guesswork, L’Oréal Cell BioPrint offers a data-driven skin care solution that allows users to make informed decisions based on their unique skin biology. This innovation underscores L’Oréal’s ongoing commitment to combining scientific research with beauty expertise.

A pilot launch of the L’Oréal-branded device in Asia is planned for late 2025, with the potential for wider rollout in the future.

Filed in Medical. Read more about KES, CES 2025 And Digital Health.